1.
Srp Arh Celok Lek
; 123(3-4): 96-9, 1995.
Artigo
em Sérvio
| MEDLINE
| ID: mdl-16296234
RESUMO
We present a pregnant woman, with diagnosis of acute myeloblastic leukemia (AML) established in the third trimester of pregnancy. She was delivered by Caesarean section at the end of 36th gestational week, and a healthy, mature-for-date, male infant was born. Combined chemotherapy (YU-AML protocol) was administered a week after the delivery, but the patient died after 7 months, due to resistant disease. We discuss actual problems that make an approach to pregnant patient with AML specific and individual.